Organogenesis (ORGO) Q4 2024 Earnings Call February 27, 2025 05:00 PM ET Company Participants Gary Gillheeney - President, CEO, Chair of the BoardDavid Francisco - Chief Financial Officer Conference Call Participants Brooks O'Neil - Senior Research AnalystRoss Osborn - Director, Lead Research Analyst - MedTech and DiagnosticsRyan Zimmerman - Managing Director & Medical Technology Analyst Operator Welcome, ladies and gentlemen, to the Fourth Quarter and Fiscal Year twenty twenty four Earnings Conference Call ...

Organogenesis (ORGO) Q4 2024 Earnings Call February 27, 2025 05:00 PM ET Company Participants Gary Gillheeney - President, CEO, Chair of the BoardDavid Francisco - Chief Financial Officer Conference Call Participants Brooks O'Neil - Senior Research AnalystRoss Osborn - Director, Lead Research Analyst - MedTech and DiagnosticsRyan Zimmerman - Managing Director & Medical Technology Analyst Operator Welcome, ladies and gentlemen, to the Fourth Quarter and Fiscal Year twenty twenty four Earnings Conference Call ...